William A. Hawkins - Mar 14, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
Director
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
3/16/2023, 09:19 PM
Previous filing
Feb 15, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +3.95K +4.28% 96.3K Mar 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +3.95K $0.00 3.95K Mar 14, 2022 Class A Common Stock 3.95K Direct F1, F2
transaction BVS Restricted Stock Units Options Exercise $0 -3.95K -100% $0.00* 0 Mar 14, 2023 Class A Common Stock 3.95K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs vest in full on March 14, 2023.